Indeed, several independent laboratories have reported that in the diagnosis of pancreatic, breast, and colon cancer, GPC1 is enriched in cancer cell–derived exosomes, thus enabling the detection of cancer and possibly response to therapy [22–32]. The gene discussed is GPC1; the disease is cancer.